FDA Drug Application (062674) for ERYTHROMYCIN ETHYLSUCCINATE by NASKA

Back to FDA Applications sponsored by NASKA

Application Number062674
Product Number001
FormSUSPENSION;ORAL
DosageEQ 400MG BASE/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameERYTHROMYCIN ETHYLSUCCINATE
Active IngredientERYTHROMYCIN ETHYLSUCCINATE

Active IngredientCount
List of drugs with Active Ingredient ERYTHROMYCIN ETHYLSUCCINATE12


Back to FDA Applications sponsored by NASKA